Where Care Excellence Meets Business Success. Transform your operations today - 0333 577 0877
We are here to help 24/7.

TenderRehabilitation servicesCPV: 85312500

BCU-CP-59436 - Detoxification Services

Rhondda Cynon Taf
Published 16 Sept, 2025
Contract Value
£5,100,000
View Official Notice

Overview

Summary, notice description and lot information

Summary of the contracting process

The NHS Wales Shared Services Partnership-Procurement Services, hosted by Velindre University NHS Trust, is currently undertaking a procurement process for the recommissioning of inpatient substance misuse detoxification services in North Wales, under the title "BCU-CP-59436 - Detoxification Services". This initiative falls within the services industry category, specifically focusing on rehabilitation services, and covers delivery addresses including UKL11, UKL12, UKL13, and UKL23 regions. The procurement is at the tender stage with an open procedure, with the submission deadline set for 7th October 2025 at midday.

The contract is valued at £5,100,000, running for 1,080 days with options for renewal. Businesses need to submit bids electronically via the eTenderwales platform. The award criteria prioritise quality over cost, reflecting a 70% quality to 30% cost ratio.

This tender offers significant opportunities for service providers specialising in healthcare, particularly those with expertise in addiction treatment and rehabilitation services, to expand their operations within the Welsh public health sector. Organisations experienced in managing or delivering high-quality inpatient detoxification services will find this project aligns with their capabilities. The contract's focus on a significant health challenge in North Wales—substance misuse—presents an impactful way for businesses to contribute to community welfare while establishing a robust presence in the region.

Potential bidders should be equipped to handle increased patient intakes and adhere to high standards of care, positioning themselves strategically to leverage the long-term engagement and renewal possibilities inherent in the contract structure.

Notice Description

The MHLD Directorate are seeking approval to recommission the inpatient substance misuse detoxification service for North Wales. The inpatient substance misuse detoxification service is for patients who have physical and/or psychological dependency to one or more substances with physical or psychiatric complications (co-morbidity) if they require a higher level of care than can be provided safely in the community. North Wales is an outlier in several areas for substance misuse as outlined.

In 2022/2023, 19 of the 22 Local Authority areas in Wales saw a decrease in rates of individuals admitted to hospital with an alcohol-specific condition. The only 3 Local Authority areas that saw an increase were Gwynedd (4 per cent) Anglesey (7 per cent) and Wrexham (10 per cent). Betsi Cadwaladr University Health Board (BCUHB) area has the highest rate of admissions related to illicit drugs (152.1 per 100,000 population) across Wales.

When looking at deaths from drug misuse for 2020-22 by local authority, Wrexham is in the top 5 local authorities with a population prevalence of 8.6 per 100,000 population compared with the Welsh average being 6.6 per 100,000 of the population. The number of patients referred for inpatient substance misuse detoxification service has steadily increased over the last three years. This is from 194 admissions in 2022, 227 admissions in 2023 and 183 in 2024 To ensure that the existing service delivery model is still fit for purpose a full options appraisal process has been undertaken following the Better Business case methodology and explored a range of potential options including BCUHB delivery and external procurement.

Lot Information1 Lot
1Untitled Lot
Active

The MHLD Directorate are seeking approval to recommission the inpatient substance misuse detoxification service for North Wales. The inpatient substance misuse detoxification service is for patients who have physical and/or psychological dependency to one or more substances with physical or psychiatric complications (co-morbidity) if they require a higher level of care than can be provided safely in the community. North Wales is an outlier in several areas for substance misuse as outlined. In 2022/2023, 19 of the 22 Local Authority areas in Wales saw a decrease in rates of individuals admitted to hospital with an alcohol-specific condition. The only 3 Local Authority areas that saw an increase were Gwynedd (4 per cent) Anglesey (7 per cent) and Wrexham (10 per cent). Betsi Cadwaladr University Health Board (BCUHB) area has the highest rate of admissions related to illicit drugs (152.1 per 100,000 population) across Wales. When looking at deaths from drug misuse for 2020-22 by local authority, Wrexham is in the top 5 local authorities with a population prevalence of 8.6 per 100,000 population compared with the Welsh average being 6.6 per 100,000 of the population. The number of patients referred for inpatient substance misuse detoxification service has steadily increased over the last three years. This is from 194 admissions in 2022, 227 admissions in 2023 and 183 in 2024 To ensure that the existing service delivery model is still fit for purpose a full options appraisal process has been undertaken following the Better Business case methodology and explored a range of potential options including BCUHB delivery and external procurement. Please see Information for Bidders document on the Bravo Solutions portal for further details. Betsi Cadwaladr University Health Board recognises the importance of the Welsh language to the communities it serves. Consequently, responses to an invitation to quote or tender will be accepted in Welsh as well as English. However, please note that tender responses submitted only in Welsh will be translated by the Trust into English before consideration. Those involved in translating the document will be barred from taking decisions on awarding tenders. The tender will be awarded based on 30% cost & 70% quality as detailed in the ITT document. Please note that the tender closing date is 07/10/2025 at midday and any late submissions will not be considered. The etenderwales bravosolution ref:Project: project_59436 and itt_120050 Please direct all queries relating to this tender via the messaging function of the Bravo portal. More details can be found at https://etenderwales.bravosolution.co.uk.

Procurement Classification

Notice type, method, and CPV codes

Open Contracting ID
ocds-h6vhtk-059ba5
Publication Source
Find A Tender Service
Notice Type
Tender Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Open
Awardee Scale
Not specified
Current Stage
Tender

Contract Values

Financial information and value estimates

Tender Value
£5,100,000
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Contract duration information not available.

Key Dates

Publication, submission, and award timeline

Tender

16 Sep 2025 at 15:56

Tender Notice

Notice Status

Current status of tender, lots, awards, and contracts

Tender Status
Active
Lots Status
Active
Awards Status
Not Specified
Contracts Status
Not Specified

Contracting Authority

Buyer organisation and contact details

NWS
NHS WALES SHARED SERVICES PARTNERSHIP-PROCUREMENT SERVICES (HOSTED BY VELINDRE UNIVERSITY NHS TRUST)
Services
Contact Name
Not specified
CARDIFF
CF15 7QZ
Wales
Wales
TLL5 South East Wales

Awarded Supplier

Supplier who was awarded this contract

?
Not specifiedAwarded
Not specified
View Profile
Number of Suppliers
0
Awards Value
Not specified

Documents & Links

External resources and data downloads

Need help with your tender submission?

Our expert team can help you prepare a winning bid. Get professional support from CareSync Experts.

Get in touch with our team at Care Sync Experts today for a consultation.

Email: hello@caresyncexperts.co.uk

Phone: 0333 577 0877

Contact Us